Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade

[1]  G. Gravlee,et al.  EFFECT OF ADVANCING AGE ON CEREBRAL BLOOD FLOW AND CMRO2 DURING HYPOTHERMIC CARDIOPULMONARY BYPASS , 1989 .

[2]  F. Donati,et al.  Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade. , 1989, Anesthesiology.

[3]  J. Wierda,et al.  Dose‐Response Relation and Time Course of Action of Pipecuronium Bromide in Humans Anesthetized with Nitrous Oxide and Isoflurane, Halothane, or Droperidol and Fentanyl , 1989, Anesthesia and analgesia.

[4]  G. Rosa,et al.  Neostigmine and edrophonium as antagonists of atracurium and pancuronium , 1988, Acta anaesthesiologica Scandinavica.

[5]  F. Donati,et al.  Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine. , 1987 .

[6]  G. Absood,et al.  Accelerated reversal of atracurium blockade with priming doses of edrophonium. , 1987, Anesthesiology.

[7]  G. Graham,et al.  Relationship of Train-of-four Ratio to Twitch Depression during Pancuronium-induced Neuromuscular Blockade , 1986, Anesthesiology.

[8]  J. P. Payne,et al.  Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium. , 1986, British journal of anaesthesia.

[9]  Ronald D. Miller,et al.  Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium. , 1986 .

[10]  G. Lavery,et al.  A Comparison of Edrophonium and Neostigmine for the Antagonism of Atracurium‐Induced Neuromuscular Block , 1985, Anesthesia and analgesia.

[11]  F. Donati,et al.  The potencies of edrophonium and neostigmine as antagonists of pancuronium , 1985, Anaesthesia.

[12]  J. Viby-Mogensen,et al.  Edrophonium and Neostigmine for Reversal of the Neuromuscular Blocking Effect of Vecuronium , 1985 .

[13]  J. Williams,et al.  Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium. , 1984, British journal of anaesthesia.

[14]  F. Donati,et al.  Twitch Depression and Train‐of–Four Ratio after Antagonism of Pancuronium with Edrophonium, Neostigmine, or Pyridostigmine , 1983, Anesthesia and analgesia.

[15]  M. Boros,et al.  Clinical experiences with pipecuronium bromide. , 1983, Acta chirurgica Hungarica.

[16]  R. Miller,et al.  Edrophonium: Duration of Action and Atropine Requirement in Humans during Halothane Anesthesia , 1982, Anesthesiology.

[17]  H. H. Ali,et al.  HISTAMINE-RELEASING POTENCIES OF ATRACURIUM BESYLATE (BW 33A), METOCURINE, AND d -TUBOCURARINE , 1982 .

[18]  J. Viby-Mogensen,et al.  Clinical assessment of neuromuscular transmission. , 1982, British journal of anaesthesia.

[19]  R. Miller,et al.  Clinical Pharmacology of ORG NC45 (NorcuronTM): A New Nondepolarizing Muscle Relaxant , 1981, Anesthesiology.

[20]  D. Bevan,et al.  Neostigmine, Pyridostigmine, and Edrophonium as Antagonists of Pancuronium , 1980, Anesthesiology.

[21]  R. Cork,et al.  DO LUNG FUNCTION TESTS IMPROVE WITH MASSIVE WEIGHT LOSS , 1980 .

[22]  E. Kárpáti,et al.  Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide. , 1980, Arzneimittel-Forschung.

[23]  I. Tóth,et al.  Comparative clinical study of pipecurium bromide and pancuronium bromide. , 1980, Arzneimittel-Forschung.

[24]  D. Bevan.  Reversal of pancuronium with edrophonium , 1979, Anaesthesia.

[25]  H. H. Ali,et al.  Evaluation of Recovery From Nondepolarizing Neuromuscular Block, Using a Digital Neuromuscular Transmission Analyzer: Preliminary Report , 1973, Anesthesia and analgesia.